Sun Pharma Recalls 3,263 Bottles of Epilepsy Drug in US

Sun Pharma is voluntarily recalling 3,263 bottles of Levetiracetam, extended release tablets, an anti-epileptic drug, in the US market.
     
As per the information available on the USFDA website, Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing "dissolution specifications".
     
The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol, it added.
     
The recall was initiated by the company on January 21 this year.
     
It has been classified as a 'Class-II recall' which FDA defined as "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote".
     
When contacted, a Sun Pharma spokesperson declined to comment.
     
Shares of Sun Pharma closed at Rs 908.70 apiece, down 0.66 per cent, on the BSE.